05/07/2013
Enfin une lueur d espoir pour nos compagnons.
Article technique mais intéressant
Jun. 21, 2013
Discovery offers hope against deadly cat virus
ByCarly Hodes
Provided
A coronavirus (red) infects intestinal cells (gray).
What makes a harmless virus turn lethal? For the deadliest infectious disease in cats, Cornell scientists now know.
After gathering the world’s largest sample collection for feline infectious peritonitis (FIP), they uncovered the holy grail of a 30-year quest for the mutation that turns it fatal. Scheduled to be published in Emerging Infectious Disease in July 2013, their study provides a long-sought breakthrough, opening the door to development of the first working diagnostics, vaccines and treatments for FIP.
Dramatic and usually fatal, FIP develops when feline enteric coronavirus (FECV), a common benign intestinal virus, mutates into the malignant FIPV virus. Discovered by a Cornell veterinarian in 1963, this mutant moves from intestinal cells to white blood cells called macrophages. Traveling through the body, it kills most cats within weeks. Kittens are particularly vulnerable, especially in shelters and catteries. Current tests cannot distinguish between the common FECV and the killer FIPV. There are no effective vaccines or therapies.
Provided
Infected macrophages (green) carrying deadly feline infectious peritonitis virus (FIPV). Macrophage nuclei glow blue.
Provided
A model of coronavirus structure. The particle's main body is crowned with spike proteins (red), which activate the virus when cleaved by the right protease.
“FIP is a tragic disease for families falling in love with new kittens and for veterinarians who can do nothing to stop it,” said Gary Whittaker, virology professor at Cornell’s College of Veterinary Medicine. “Comparing viral genetics, our lab found exactly what changes when FECV mutates into FIPV. This knowledge will prove pivotal in developing tests, vaccines and treatments to protect cats from this devastating disease.”
Scientists have searched for this mutation for the last three decades. Part of the challenge, Whittaker said, might have been the scale at which they searched. Like flu viruses, coronaviruses code genes with RNA. RNA-based viruses make many mistakes when replicating, allowing them to quickly mutate, dodge vaccines and therapeutics, and move to new territory.
“These viruses are so rife with mutations that even samples of the same virus from the same tissue in the same cat rarely match to the letter,” said Whittaker. “Sifting through for something that distinguishes FIPV was like looking for a needle in a haystack.”
So Whittaker deviated from taking the traditional birds-eye view, focusing instead on a specific functional part of the virus. Coronavirus particles brim with crowns of spikey proteins that activate the virus when chopped by the right proteases – ax-like enzymes in the host cell. FECV prefers proteases from its main ride, intestinal cells. When FIPV hijacks macrophages instead, Whittaker suspected its spike proteins have changed shape to respond to macrophage proteases.
Using novel biochemical analysis and traditional comparative genomic analysis, Whittaker focused on the area where proteases cut spike proteins. He amassed an unprecedented collection of feline coronavirus, gathering hundreds of samples donated from pet owners, veterinarians and – with help from pathology professor Gerald Duhamel – Cornell’s pathology vault.
Whittaker
Comparing the spot in quiet FECV to the same spot in killer FIPV, he found a distinct set of differences in the spike proteins and the genes that code them. This set of mutations matched FIPV’s behavioral change and appeared across samples with consistency unparalleled in the quest for the mutation.
“Using a unique interdisciplinary approach, we’ve found the first known molecular basis for FIP,” said Whittaker. “This could have implications for similar coronaviruses, such as FIPV’s deadly cousin in ferrets and another human-infecting cousin emerging in the Middle East. For now, it finally unlocks the door to developing the world’s first effective diagnostics, preventions and therapies for FIP in cats.”
The research was funded by Cornell’s Feline Health Center, the Winn Feline Foundation and the Morris Animal Foundation.
Carly Hodes ’10, MBA ’15, is a communications specialist at the College of Veterinary Medicine.
